- Oops!Something went wrong.Please try again later.
STMicroelectronics NV (NYSE: STM) and Korean medical device manufacturer Nu Eyne jointly announced a Nu Eyne wearable therapy device for eye care powered by an STM32WB55 dual-core Bluetooth LE (BLE) microcontroller (MCU).
Nu Eyne's recently launched CELLENA wearable device uses electric current and light emitted to the eyes and associated nerves to relieve eye dryness and fatigue.
The CELLENA device relies on the dual-core architecture of the STM32WB55 MCU for wireless connectivity and real-time processing.
ST's MCU also delivers multiple security mechanisms, including user data protection and encrypted firmware update over BLE with its embedded security features.
Price Action: STM shares traded higher by 0.81% at $43.69 in the premarket session on the last check Thursday.
See more from Benzinga
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.